OUR RESOURCES

All of Biotech and Money's content, in one place.

Community Partners

 

DEALS WATCH

Medius Deal Watch May Part II

Good morning, good morning

Read More

Medius Deal Watch May 2017 Part I

Following the scarcity of billion dollar headline deals in March, this mont...

Read More
VIEW MORE

EXECUTIVE AND EXPERT INSIGHTS

Will Horizon successfully navigate the path to profit?

Currently one of the most successful life science companies in the country,...

Read More

Management to investors: the communicative conundrum

We have published our annual investor perception survey, confirming or disp...

Read More

All in the Delivery - Interview with Simon Newman, CSO, Ryboquin

Biotech and Money recently talked to Simon Newman, CSO of Ryboquin, about t...

Read More

Interview with Daniel Oliver, CEO of Capital Cell

Daniel Oliver, CEO of Capital Cell, recently took the time to grant us an i...

Read More

Patenting problems specific to the biotech and healthcare sector

This is the fourth and final article in our series that aims to provide tip...

Read More

Nine things we learned from Centauri CEO Mike Westby

Biotech and Money recently talked to Mike Westby, CEO of Centauri, about th...

Read More

Interview with Dr Sara Nunez-Garcia, Principal, Sofinnova Partners

Phacilitate's Investment for Advanced Therapies in partnership with Biotech...

Read More
View More

EXECUTIVE PUBLICATIONS AND REPORTS

Must-Know Finance Concepts for Life Sciences Valuations

By John Selig, Co-Founder and Managing Partner, Mavericks Capital When sell...

Read More

The Nuts & Bolts of Due Diligence in Biopharma Partnering

Based on a web panel discussion presented by ShareVault in association with...

Read More

Attracting investment to the UK Life Sciences sector

Our Investor Perception Survey 2017 highlighted key trends around M&A, Inve...

Read More

Investment trends and outlook in 2017

Our Investor Perception Survey 2017 highlighted key trends around M&A, Inve...

Read More

Self-perpetuating myths and attitudes in the Biotech sector

There are several self-perpetuating myths and attitudes in the Biotech sect...

Read More

Issue 11, Drugs & Dealers Magazine Released

Biotech and Money are pleased to announce the release of the latest Drugs &...

Read More

[REPORT] Trends and Truth in Life Sciences Investment

We are delighted to announce the launch of Biotech and Money's Investor Per...

Read More

35+ Innovative Life Science Companies you'll want to meet in 2017

Who are the innovative biotech and medtech companies presenting at Biotech ...

Read More
View More

INVESTORVIEWS

Investorview – Precision Investing with Jay Goth, Managing Partner, Forentis Fund

Our latest investorview is, this week, with Jay Goth, Managing Partner of t...

Read More

Investorview – Zishan Haroon, Chairman & General Partner at ‎Julz Co

In a new regular feature for Drugs & Dealers, we’ll be interviewing some of...

Read More
VIEW MORE